Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 4
2013 4
2014 1
2015 1
2016 1
2017 1
2018 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Results by year
Filters applied: . Clear all
Page 1
Development of Protective Immunity in New Zealand White Rabbits Challenged with Bacillus anthracis Spores and Treated with Antibiotics and Obiltoxaximab, a Monoclonal Antibody against Protective Antigen.
Henning LN, Carpenter S, Stark GV, Serbina NV. Henning LN, et al. Among authors: stark gv. Antimicrob Agents Chemother. 2018 Jan 25;62(2):e01590-17. doi: 10.1128/AAC.01590-17. Print 2018 Feb. Antimicrob Agents Chemother. 2018. PMID: 29133571 Free PMC article. Clinical Trial.
Efficacy Projection of Obiltoxaximab for Treatment of Inhalational Anthrax across a Range of Disease Severity.
Yamamoto BJ, Shadiack AM, Carpenter S, Sanford D, Henning LN, O'Connor E, Gonzales N, Mondick J, French J, Stark GV, Fisher AC, Casey LS, Serbina NV. Yamamoto BJ, et al. Among authors: stark gv. Antimicrob Agents Chemother. 2016 Sep 23;60(10):5787-95. doi: 10.1128/AAC.00972-16. Print 2016 Oct. Antimicrob Agents Chemother. 2016. PMID: 27431222 Free PMC article.
Correlation between anthrax lethal toxin neutralizing antibody levels and survival in guinea pigs and nonhuman primates vaccinated with the AV7909 anthrax vaccine candidate.
Savransky V, Shearer JD, Gainey MR, Sanford DC, Sivko GS, Stark GV, Li N, Ionin B, Lacy MJ, Skiadopoulos MH. Savransky V, et al. Among authors: stark gv. Vaccine. 2017 Sep 5;35(37):4952-4959. doi: 10.1016/j.vaccine.2017.07.076. Epub 2017 Jul 31. Vaccine. 2017. PMID: 28774566 Free PMC article.
Efficacy and immunogenicity of single-dose AdVAV intranasal anthrax vaccine compared to anthrax vaccine absorbed in an aerosolized spore rabbit challenge model.
Krishnan V, Andersen BH, Shoemaker C, Sivko GS, Tordoff KP, Stark GV, Zhang J, Feng T, Duchars M, Roberts MS. Krishnan V, et al. Among authors: stark gv. Clin Vaccine Immunol. 2015 Apr;22(4):430-9. doi: 10.1128/CVI.00690-14. Epub 2015 Feb 11. Clin Vaccine Immunol. 2015. PMID: 25673303 Free PMC article.
Clinical profiles associated with influenza disease in the ferret model.
Stark GV, Long JP, Ortiz DI, Gainey M, Carper BA, Feng J, Miller SM, Bigger JE, Vela EM. Stark GV, et al. PLoS One. 2013;8(3):e58337. doi: 10.1371/journal.pone.0058337. Epub 2013 Mar 5. PLoS One. 2013. PMID: 23472182 Free PMC article.
Pathology and pathophysiology of inhalational anthrax in a guinea pig model.
Savransky V, Sanford DC, Syar E, Austin JL, Tordoff KP, Anderson MS, Stark GV, Barnewall RE, Briscoe CM, Lemiale-Biérinx L, Park S, Ionin B, Skiadopoulos MH. Savransky V, et al. Among authors: stark gv. Infect Immun. 2013 Apr;81(4):1152-63. doi: 10.1128/IAI.01289-12. Epub 2013 Jan 28. Infect Immun. 2013. PMID: 23357384 Free PMC article.
Evaluation of immunogenicity and efficacy of anthrax vaccine adsorbed for postexposure prophylaxis.
Ionin B, Hopkins RJ, Pleune B, Sivko GS, Reid FM, Clement KH, Rudge TL Jr, Stark GV, Innes A, Sari S, Guina T, Howard C, Smith J, Swoboda ML, Vert-Wong E, Johnson V, Nabors GS, Skiadopoulos MH. Ionin B, et al. Among authors: stark gv. Clin Vaccine Immunol. 2013 Jul;20(7):1016-26. doi: 10.1128/CVI.00099-13. Epub 2013 May 8. Clin Vaccine Immunol. 2013. PMID: 23658392 Free PMC article. Clinical Trial.
Anthrax vaccine-induced antibodies provide cross-species prediction of survival to aerosol challenge.
Fay MP, Follmann DA, Lynn F, Schiffer JM, Stark GV, Kohberger R, Quinn CP, Nuzum EO. Fay MP, et al. Among authors: stark gv. Sci Transl Med. 2012 Sep 12;4(151):151ra126. doi: 10.1126/scitranslmed.3004073. Sci Transl Med. 2012. PMID: 22972844 Free PMC article.
Development of an inhalational Bacillus anthracis exposure therapeutic model in cynomolgus macaques.
Henning LN, Comer JE, Stark GV, Ray BD, Tordoff KP, Knostman KA, Meister GT. Henning LN, et al. Among authors: stark gv. Clin Vaccine Immunol. 2012 Nov;19(11):1765-75. doi: 10.1128/CVI.00288-12. Epub 2012 Sep 5. Clin Vaccine Immunol. 2012. PMID: 22956657 Free PMC article.
Protection of ferrets from pulmonary injury due to H1N1 2009 influenza virus infection: immunopathology tractable by sphingosine-1-phosphate 1 receptor agonist therapy.
Teijaro JR, Walsh KB, Long JP, Tordoff KP, Stark GV, Eisfeld AJ, Kawaoka Y, Rosen H, Oldstone MB. Teijaro JR, et al. Among authors: stark gv. Virology. 2014 Mar;452-453:152-7. doi: 10.1016/j.virol.2014.01.003. Epub 2014 Jan 31. Virology. 2014. PMID: 24606692 Free PMC article.
14 results
Jump to page